SANTINI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 465
EU - Europa 191
AS - Asia 51
Totale 707
Nazione #
US - Stati Uniti d'America 465
SE - Svezia 51
IT - Italia 49
IE - Irlanda 45
CN - Cina 22
SG - Singapore 18
UA - Ucraina 18
GB - Regno Unito 12
DE - Germania 9
IN - India 6
FI - Finlandia 3
AT - Austria 2
DK - Danimarca 2
ID - Indonesia 2
VN - Vietnam 2
KR - Corea 1
Totale 707
Città #
Chandler 86
Ashburn 55
Dublin 45
Fairfield 44
New York 28
Jacksonville 25
Lawrence 20
Princeton 20
Houston 16
Turin 16
San Diego 13
Seattle 13
Wilmington 12
Washington 10
Woodbridge 9
Beijing 8
Boardman 8
Cambridge 7
London 6
Ann Arbor 5
San Mateo 5
Macerata 4
Hanoi 2
Helsinki 2
Marche 2
Mountain View 2
Palermo 2
Pune 2
Redwood City 2
Vienna 2
Casalbordino 1
Chiswick 1
Falkenstein 1
Guangzhou 1
Jiaxing 1
Jinhua 1
Kilburn 1
Los Angeles 1
Miami Beach 1
Shanghai 1
Southwark 1
Wuhu 1
Totale 483
Nome #
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 71
Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR) 67
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study 59
Role of STAT3 pathway in genitourinary tumors 54
Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy 52
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 47
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting 43
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? [Ann Oncol, 23, 9, (2012) (2313-2318)] doi: 10.1093/annonc/mdr623 40
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 34
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 31
Driver mutations and differential sensitivity to targeted therapies: A new approach to the treatment of lung adenocarcinoma 29
Germline copy number variation in the YTHDC2 gene: Does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 29
Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: A literature-based meta-analysis 28
Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 27
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: A retrospective analysis 26
Prognostic vs predictive molecular biomarkers in colorectal cancer: Is KRAS and BRAF wild type status required for anti-EGFR therapy? 25
Predicting efficacy and toxicity in the era of targeted therapy: Focus on anti-EGFR and anti-VEGF molecules 25
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 24
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients 22
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: There is a sense in antisense? 20
Totale 753
Categoria #
all - tutte 6.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 2 2 5 0 5 0 5 3 6 6
2020/202193 9 6 17 0 8 7 8 8 11 8 9 2
2021/2022134 4 5 4 0 1 3 0 4 35 16 41 21
2022/2023273 20 28 34 10 15 33 1 12 68 1 43 8
2023/2024196 26 5 19 24 29 59 2 8 0 1 14 9
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 753